|
Market Closed -
Nasdaq
23:00:00 04/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.480 USD | +8.03% |
|
-10.57% | -75.82% |
Evolution of the Average Target: Actuate Therapeutics, Inc.
Evolution of the Target Price: Actuate Therapeutics, Inc.
Changes in Analyst Recommendations: Actuate Therapeutics, Inc.
dd8a1f8f8ef223f24620c.tDTV1GN8Vw5zNOqiMuclqD97xL1s_s-x-gsQAx9YpLU.432KrlY9H383f9PHR65f0W8ahskmnKLWq391bn4gyvCHQIOsOk8-azhxnQ~dfc6b1caf8a4b65019cd09c139b0b12e
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +752.8% | |||||
| +18.92% | |||||
| +9.64% | |||||
| +58.02% | |||||
| +13.1% | |||||
| +16.97% | |||||
| +10.47% | |||||
| +3.5% | |||||
| +24.48% | |||||
| -9.2% | |||||
| Average | +89.87% | |||||
| Weighted average by Cap. | +17.20% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.480USD
Average target price
11.68USD
Spread / Average Target
+689.41%
High Price Target
15.05USD
Spread / Highest target
+916.89%
Low Price Target
8.000USD
Spread / Lowest Target
+440.54%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- ACTU Stock
- Consensus Actuate Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
